Mouse strain-dependent variation in metabolic associated fatty liver disease (MAFLD): a comprehensive resource tool for pre-clinical studies
These gastrointestinal symptoms are typically most pronounced during dose escalation and tend to diminish over time as patients develop tolerance
Compounds that threaten existing revenue streams face institutional resistance that extends far beyond scientific review
Mao C, Liu X, Yan Y, Olszewski K, Gan B
"A young man escalated his dose of retatrutide, he experienced secretory diarrhoea, which was very severe, and he was admitted to hospital requiring a lot of intravenous fluid rehydration," Dr Holt said
These drugs improve blood sugar levels and help with weight loss, helping many patients